188 related articles for article (PubMed ID: 19939587)
1. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
Weinberger AH; Reutenauer EL; Jatlow PI; O'Malley SS; Potenza MN; George TP
Drug Alcohol Depend; 2010 Mar; 107(2-3):188-95. PubMed ID: 19939587
[TBL] [Abstract][Full Text] [Related]
2. Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy.
Killen JD; Fortmann SP; Murphy GM; Hayward C; Fong D; Lowenthal K; Bryson SW; Killen DT; Schatzberg AF
Addiction; 2010 Sep; 105(9):1660-8. PubMed ID: 20707784
[TBL] [Abstract][Full Text] [Related]
3. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers.
Berlin I; Saïd S; Spreux-Varoquaux O; Launay JM; Olivares R; Millet V; Lecrubier Y; Puech AJ
Clin Pharmacol Ther; 1995 Oct; 58(4):444-52. PubMed ID: 7586937
[TBL] [Abstract][Full Text] [Related]
4. A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation.
George TP; Vessicchio JC; Termine A; Jatlow PI; Kosten TR; O'Malley SS
Biol Psychiatry; 2003 Jan; 53(2):136-43. PubMed ID: 12547469
[TBL] [Abstract][Full Text] [Related]
5. A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch.
Berlin I; Hunneyball IM; Greiling D; Jones SP; Fuder H; Stahl HD
Psychopharmacology (Berl); 2012 Sep; 223(1):89-98. PubMed ID: 22451094
[TBL] [Abstract][Full Text] [Related]
6. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.
Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Ameli N; Schatzberg AF; Murphy GM
Nicotine Tob Res; 2015 Sep; 17(9):1126-33. PubMed ID: 25572450
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation.
Biberman R; Neumann R; Katzir I; Gerber Y
Addiction; 2003 Oct; 98(10):1403-7. PubMed ID: 14519177
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
[TBL] [Abstract][Full Text] [Related]
9. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.
Batra A; Klingler K; Landfeldt B; Friederich HM; Westin A; Danielsson T
Clin Pharmacol Ther; 2005 Dec; 78(6):689-96. PubMed ID: 16338284
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler.
Kralikova E; Kozak JT; Rasmussen T; Gustavsson G; Le Houezec J
BMC Public Health; 2009 Nov; 9():433. PubMed ID: 19943947
[TBL] [Abstract][Full Text] [Related]
11. Predicting smoking cessation. Who will quit with and without the nicotine patch.
Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
[TBL] [Abstract][Full Text] [Related]
12. Predicting successful 24-hr quit attempt in a smoking cessation intervention.
Bailey SR; Bryson SW; Killen JD
Nicotine Tob Res; 2011 Nov; 13(11):1092-7. PubMed ID: 21832272
[TBL] [Abstract][Full Text] [Related]
13. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
Robles GI; Singh-Franco D; Ghin HL
Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
[TBL] [Abstract][Full Text] [Related]
14. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
[TBL] [Abstract][Full Text] [Related]
15. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
Winhusen TM; Somoza EC; Brigham GS; Liu DS; Green CA; Covey LS; Croghan IT; Adler LA; Weiss RD; Leimberger JD; Lewis DF; Dorer EM
J Clin Psychiatry; 2010 Dec; 71(12):1680-8. PubMed ID: 20492837
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE
Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918
[TBL] [Abstract][Full Text] [Related]
17. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
[TBL] [Abstract][Full Text] [Related]
18. Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation.
Weinberger AH; McKee SA; George TP
Nicotine Tob Res; 2010 Sep; 12(9):937-43. PubMed ID: 20644207
[TBL] [Abstract][Full Text] [Related]
19. Effects of selegiline (L-deprenyl) during smoking and short-term abstinence.
Houtsmuller EJ; Thornton JA; Stitzer ML
Psychopharmacology (Berl); 2002 Sep; 163(2):213-20. PubMed ID: 12202968
[TBL] [Abstract][Full Text] [Related]
20. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
